Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT Retreatment: Tofacitinib in Psoriasis
NCT01186744Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of tofacitinib oral solution in plaque psoriasis, sponsored by Pfizer. Started Sep 2010; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01186744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186744.